Brexpiprazole in the treatment of schizophrenia and agitation in Alzheimer's disease.

Stummer, Lauren; Markovic, Marija; Maroney, Megan

Stummer, Lauren; Markovic, Marija; Maroney, Megan.

Afiliação

Stummer L; Department of Pharmacy, McLean Hospital, 115 Mill Street Belmont, MA 02478, USA.
Markovic M; Department of Pharmacy, Hackensack University Medical Center, 30 Prospect Ave, Hackensack, NJ 07601, USA.
Maroney M; Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, Department of Pharmacy, Monmouth Medical Center, 300 Second Avenue, Long Branch, NJ 07740, USA.

Neurodegener Dis Manag ; 10(4): 205-217, 2020 08.

Article em En | MEDLINE | ID: mdl-32618483

Assuntos

Doença de Alzheimer/tratamento farmacológico; Antipsicóticos/uso terapêutico; Quinolonas/uso terapêutico; Esquizofrenia/tratamento farmacológico; Tiofenos/uso terapêutico; Humanos

Palavras-chave

Alzheimer's disease; D2 partial agonist; Rexulti®; agitation; brexpiprazole; dementia; schizophrenia; second-generation antipsychotic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Tiofenos / Antipsicóticos / Quinolonas / Doença de Alzheimer Limite: Humans Idioma: En Revista: Neurodegener Dis Manag Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google